Bausch + Lomb BLCO Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Pharmaceuticals | $1.13B+14.6% | $1.08B+11.6% | $1.03B+6.8% | $997M+20.1% | $982M+36.6% | |
| Surgical | $908M+5.6% | $894M+6.0% | $876M+7.4% | $867M+9.1% | $860M+10.1% | |
| Vision Care | $2.98B+7.9% | $2.92B+6.7% | $2.87B+7.1% | $2.82B+6.6% | $2.76B+6.5% | |
| Total revenues by Product | ||||||
| Branded and Other Generics | $237M-11.9% | $242M-13.9% | $240M-8.7% | $251M-5.3% | $269M+4.7% | |
| Devices | $1.95B+7.1% | $1.92B+6.8% | $1.88B+7.5% | $1.85B+8.6% | $1.82B+9.4% | |
| OTC | $1.87B+7.6% | $1.84B+6.4% | $1.81B+6.9% | $1.77B+5.6% | $1.74B+5.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch + Lomb break its business down?
- Bausch + Lomb (BLCO) reports total revenues by business across 3 parts — Pharmaceuticals, Surgical and Vision Care. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch + Lomb's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch + Lomb's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.